1. Home
  2. Author
  3. Kratochvil CJ

Kratochvil CJ

References (2)

Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715
Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD
Ref : Psychopharmacology (Berl) , 219 :715 , 2012
Abstract : Apostol_2012_Psychopharmacology.(Berl)_219_715
ESTHER : Apostol_2012_Psychopharmacology.(Berl)_219_715
PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715
PubMedID: 21748252

Title : Safety and efficacy of ABT-089 in pediatric attention-deficit\/hyperactivity disorder: results from two randomized placebo-controlled clinical trials - Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73
Author(s) : Wilens TE , Gault LM , Childress A , Kratochvil CJ , Bensman L , Hall CM , Olson E , Robieson WZ , Garimella TS , Abi-Saab WM , Apostol G , Saltarelli MD
Ref : J Am Acad Child Adolesc Psychiatry , 50 :73 , 2011
Abstract : Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73
ESTHER : Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73
PubMedSearch : Wilens_2011_J.Am.Acad.Child.Adolesc.Psychiatry_50_73
PubMedID: 21156272